Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach.

This publication has 12 references indexed in Scilit:

• Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs
  BMJ, 2002
• Drug policy: making effective drugs available without bankrupting the healthcare system.
  HealthcarePapers, 2002
• Look beyond budgets to the broader benefits.
  HealthcarePapers, 2002
• Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors
  New England Journal of Medicine, 2002
• Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones?
  2002
• Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study
  American Journal of Gastroenterology, 2001
• The role of databases in drug postmarketing surveillance
  Pharmacoepidemiology and Drug Safety, 2001
• The Impact of Combined Inhaled Bronchodilator Therapy in the Treatment of COPD
  Chest, 2001
• Physician characteristics in relation to cardiovascular drugs commonly prescribed for hypertension in Nova Scotia.
  2001
• Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: Retrospective cohort study of an elderly population
  Arthritis & Rheumatism, 2000